Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia: HABENOX: A randomised multicentre trial
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Summary: Recurrent miscarriage affects 1–2% of women. In more than half of all recurrent miscarriage the cause still remains uncertain. Thrombophilia has been identified in about 50% of women with recurrent miscarriage and thromboprophylaxis has been suggested as an option of treatment. A randomised double-blind (for aspirin) multicentre trial was performed among 207 women with three or more consecutive first trimester (<13 weeks) miscarriages, two or more second trimester (13–24 weeks) miscarriages or one third trimester fetal loss combined with one first trimester miscarriage. Women were analysed for thrombophilia. After complete work-up, women were randomly allocated before seven weeks’ gestation to either enoxaparin 40 mg and placebo (n=68), enoxaparin 40 mg and aspirin 100 mg (n=63) or aspirin 100 mg (n=76). The primary outcome was live-birth rate. Secondary outcomes were pregnancy complications, neonatal outcome and adverse effects. The 0.92–1.48] was found for enoxaparin and placebo and 65% [RR 1.08, 95% CI 0.83–1.39] for enoxaparin and aspirin when compared to aspirin alone (61%, reference group). In the whole study group the live birth rate was 65% (95% CI 58.66–71.74) for women with three or more miscarriages (n=204). No difference in pregnancy complications, neonatal outcome or adverse effects was observed. No significant difference in live birth rate was found with enoxaparin treatment versus aspirin or a combination of both versus aspirin in women with recurrent miscarriage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a later RCT, subgroup analysis of women with recurrent miscarriage with and without thrombophilia did not demonstrate a significant difference in live birth rate when comparing enoxaparin alone, enoxaparin/aspirin combined, and aspirin alone.179”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [179]
Citations
Cites
1 retracted
Badawy, A. M., Khiary, M., Sherif, L. S., Hassan, M., Ragab, A., & Abdelall, I. (2008) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610802042688 · Cited by 109
RetractedRai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 803
Greer, I. A., & Nelson-Piercy, C. (2005) · Blood · doi:10.1182/blood-2005-02-0626 · Cited by 797
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Jauniaux, E. (2006) · Human Reproduction · doi:10.1093/humrep/del150 · Cited by 520
Epidemiology and the medical causes of miscarriage
Regan, L., & Rai, R. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2000.0123 · Cited by 512
A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage
Brigham, S. A., Conlon, C., & Farquharson, R. G. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2868 · Cited by 365
Aspirin Plus Heparin or Aspirin Alone in Women With Recurrent Miscarriage
Kaandorp, S. P., Goddijn, M., van der Post, J. A. M., Hutten, B. A., Verhoeve, H. R., Hamulyák, K., Willem Mol, B., Folkeringa, N., Nahuis, M., Papatsonis, D. N. M., et al. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182021f71 · Cited by 364
Cited by
Venous Thromboembolism and Antithrombotic Therapy in Pregnancy
Chan, W.-S., Rey, E., Kent, N. E., Chan, W.-S., Kent, N. E., Rey, E., Corbett, T., David, M., Douglas, M. J., Gibson, P. S., et al. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30569-7 · Cited by 315
Rodger, M. A., Hague, W. M., Kingdom, J., Kahn, S. R., Karovitch, A., Sermer, M., Clement, A. M., Coat, S., Chan, W. S., Said, J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60793-5 · Cited by 256
Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period
Bain, E., Wilson, A., Tooher, R., Gates, S., Davis, L.-J., & Middleton, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001689.pub3 · Cited by 235
Rodger, M. A., Gris, J.-C., de Vries, J. I. P., Martinelli, I., Rey, É., Schleussner, E., Middeldorp, S., Kaaja, R., Langlois, N. J., Ramsay, T., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31139-4 · Cited by 228
Self-citationHamulyák, E. N., Scheres, L. J. J., Marijnen, M. C., Goddijn, M., & Middeldorp, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012852.pub2 · Cited by 207
Metadata
- Authors
- Visser, J., Ulander, V.-M., Helmerhorst, F., Lampinen, K., Morin-Papunen, L., Bloemenkamp, K., & Kaaja, R.
- Affiliations
- Leiden University Medical Center (NL)
- Helsinki University Hospital (FI)
- Karolinska University Hospital (SE)
- Oulu University Hospital (FI)
- Corresponding author
- Kaaja, Risto
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2011
- Volume
- 105
- Issue
- 02
- Pages
- 295-301
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1728091354
- Cited by
- 172
- References
- 29
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 9 · 2021: 9 · 2020: 10 · 2019: 11 · 2018: 13 · 2017: 19 · 2016: 14 · 2015: 21 · 2014: 20 · 2013: 11 · 2012: 11
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- recurrent pregnancy loss, thromboprophylaxis, thrombophilia, enoxaparin, aspirin, live birth rate, pregnancy complications, neonatal outcomes, anticoagulation
- MeSH terms
- Abortion, Habitual, Adolescent, Adult, Aspirin, Double-Blind Method, Drug Therapy, Combination, Europe, Female, Fibrinolytic Agents, Gestational Age, Humans, Pregnancy, Treatment Outcome, Enoxaparin, Patient Selection, Thrombophilia, Live Birth, Young Adult, Early Termination of Clinical Trials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia: HABENOX: A randomised multicentre trial. https://app.cochat.ai/papers/10.1160/th10-05-0334
- The paper
- Visser, J., Ulander, V.-M., Helmerhorst, F., Lampinen, K., Morin-Papunen, L., Bloemenkamp, K., & Kaaja, R. (2011). Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia: HABENOX: A randomised multicentre trial. Thrombosis and Haemostasis. https://doi.org/10.1160/th10-05-0334
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.